A Risk Sciences International Case Study

Validation and Optimization of the Computational Tool for the Microbial Risk Assessment Framework (MRAF)

Microbial risk

Client: Health Canada

Listing of the client in no way affirms the client's support, sponsorship, or validation in any form of Risk Sciences International or the RSI staff member(s) who conducted this project during their stay with RSI or prior to joining the company. This case study is displayed for informative purposes only to demonstrate the capacity of RSI staff members. This case study reveals no proprietary information or information deemed sensitive.

Project description:

Validation and Optimization of the Computational Tool for the Microbial Risk Assessment Framework (MRAF)

To support more consistent and quantitative assessments of new micro-organisms under the Canadian Environmental Protection Act, Health Canada's New Substances Program (NSP) sought to refine the tools and processes within its Microbial Risk Assessment Framework (MRAF). The NSP had previously collaborated with RSI to review and modernize the MRAF and develop a supporting computational tool. However, further work was required to validate the tool and ensure it aligned with current program needs and regulatory expectations.

RSI was engaged to validate and optimize the computational tool, with particular focus on integrating new input types, verifying technical fixes, and refining outputs to support robust and efficient risk assessments. Key tasks included assessing the feasibility of incorporating alternative quantity units and additional modelling features, reviewing updates made by the client, and simplifying processes for estimating disease burden metrics such as disability-adjusted life years (DALYs). RSI also provided recommendations on how the tool could better account for genetic modifications, include guiding content for users, and support interpretation of environmental risk scores.

Beyond tool optimization, RSI was tasked with reviewing the revised MRAF to ensure alignment with the tool’s outputs and risk characterization approaches. Feedback included how to integrate computational results into supporting documents used for regulatory decisions and how to streamline these templates to reduce unnecessary content. Where time permitted, the project also explored global sensitivity analysis and the potential for incorporating stochastic modelling approaches. These enhancements aimed to strengthen NSP’s ability to conduct timely, science-based assessments of microbial risks.

Start: 2020

End: 2020

Experts related to this case study

Emma Hartnett

Vice-President Risk Modelling and Simulation

Dr. Emma Hartnett is Vice-President, Risk Modelling and Simulation at Risk Sciences International (RSI), where she has been a foundational member since its inception in 2006. A globally recognized authority in quantitative risk assessment (QRA), she specializes in developing risk...
Read More about Emma Hartnett

Margaret Wilson

Senior Risk Analyst

Margaret Wilson is a Senior Risk Analyst at Risk Sciences International (RSI), where she has been a foundational member since the company’s inception in 2006. Drawing on a rare combination of scientific breadth and analytical precision, Margaret has supported and...
Read More about Margaret Wilson

More RSI Case Studies

RSI presents a very small selection of case studies to highlight some of its key work.

External Peer Review of the Draft Screening Assessment Report on Selected C3-C5 Alcohols

To support the quality and defensibility of regulatory decision-making under the Canadian Environmental Protection Act, 1999 (CEPA), Health Canada engaged Risk Sciences International to coordinate an independent external peer review of the Draft Screening Assessment Report (DSAR) for Selected C3-C5...
Read More about External Peer Review of the Draft Screening Assessment Report on Selected C3-C5 Alcohols

Assessing the Impact of Interstudy Variation in LOAELs on Findings of Low-Dose Additivity in In Vivo Studies of Mixtures

Demonstrating the safe use of chemical mixtures remains a critical challenge in toxicological science. In recent years, studies have suggested that chemicals can exhibit dose additivity—causing a combined effect—even when each chemical individually is below its effect threshold. This project...
Read More about Assessing the Impact of Interstudy Variation in LOAELs on Findings of Low-Dose Additivity in In Vivo Studies of Mixtures

External Peer Consultation of the Inorganic – Late Biomonitoring Approach Draft Screening Assessment Report

To support the Chemicals Management Plan under the Canadian Environmental Protection Act (CEPA), Health Canada sought expert peer consultation for a draft screening assessment report (DSAR) evaluating 47 inorganic substances identified as priorities. The client required independent scientific and technical...
Read More about External Peer Consultation of the Inorganic – Late Biomonitoring Approach Draft Screening Assessment Report

Update of WHO Guidance on Food Defense

To support international efforts in mitigating deliberate threats to the food system, the World Health Organization commissioned an update to its earlier guidance titled Terrorist Threats to Food. The revision aimed to broaden the original scope by addressing not only...
Read More about Update of WHO Guidance on Food Defense

Pickering Nuclear Facility Re‑licensing

The client sought support to finalize a Commission Member Document (CMD) for the re‑licensing of a nuclear facility. Recognizing the complexity and sensitivity of reactor re‑licensing, they requested assistance in crafting communication materials that were both technically comprehensive and accessible...
Read More about Pickering Nuclear Facility Re‑licensing

Systematic Review of Artificial Sweeteners and Health Risks

A comprehensive systematic review was undertaken to assess experimental evidence regarding the potential health risks associated with artificial sweeteners, specifically focusing on cancer and pre-term delivery. The client sought a rigorous analysis of both in vivo and in vitro experimental...
Read More about Systematic Review of Artificial Sweeteners and Health Risks